Saltar al contenido
Merck

Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Chest (1998-03-14)
P W Wong, N Macris, L DiFabrizio, N S Seriff
RESUMEN

A 69-year-old man with advanced prostate cancer was receiving antiandrogen therapy (bicalutamide [Casodex]). He developed dyspnea, peripheral eosinophilia and bilateral pulmonary interstitial infiltrates. Transbronchial biopsy confirmed pulmonary eosinophilia. Withdrawal of bicalutamide and initiation of steroid therapy resulted in clinical improvement.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Bicalutamide (CDX), ≥98% (HPLC), powder
Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Bicalutamide, European Pharmacopoeia (EP) Reference Standard